Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thrombocythemia, Essential × talazoparib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 12 Prostatic Neoplasms 9 Neoplasm Metastasis 6 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Neoplasms 4 Endometrial Neoplasms 3 Small Cell Lung Carcinoma 2 Fallopian Tube Neoplasms 2 mCRPC 1 Wilms Tumor 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Pheochromocytoma 1 Pathologic Complete Response 1 Paraganglioma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1

Interventions

ruxolitinib 8 bomedemstat 3 Specimen Handling 3 Biopsy 3 fludarabine phosphate 2 Whole-Body Irradiation 2 Tacrolimus 2 Stem Cell Transplantation 2 Mycophenolic Acid 2 Methotrexate 2 Melphalan 2 Injections 2 Cyclophosphamide 2 venetoclax 1 veliparib 1 poly ICLC 1 piperine 1 pevonedistat 1 iadademstat 1 givinostat hydrochloride 1 givinostat 1 fludarabine 1 fedratinib 1 demethoxycurcumin 1 decitabine and cedazuridine drug combination 1 anagrelide 1 X-Rays 1 Valganciclovir 1 Topotecan 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡